BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.260
-0.020 (-0.88%)
At close: Jul 16, 2025, 4:00 PM
2.260
0.00 (0.00%)
After-hours: Jul 16, 2025, 4:00 PM EDT
BioCardia Revenue
BioCardia had revenue of $3.00K in the twelve months ending March 31, 2025, down -99.36% year-over-year. In the year 2024, BioCardia had annual revenue of $58.00K, down -87.84%.
Revenue (ttm)
$3.00K
Revenue Growth
-99.36%
P/S Ratio
4,107.61
Revenue / Employee
$150
Employees
20
Market Cap
12.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.00K | -419.00K | -87.84% |
| Dec 31, 2023 | 477.00K | -875.00K | -64.72% |
| Dec 31, 2022 | 1.35M | 337.00K | 33.20% |
| Dec 31, 2021 | 1.02M | 870.00K | 600.00% |
| Dec 31, 2020 | 145.00K | -565.00K | -79.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
BCDA News
- 2 months ago - BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025 - GlobeNewsWire
- 2 months ago - BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioCardia Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 2 months ago - BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025 - GlobeNewsWire
- 3 months ago - BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study - GlobeNewsWire
- 3 months ago - BioCardia, Inc. (BCDA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioCardia's Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today - GlobeNewsWire
- 4 months ago - BioCardia Reports 2024 Business Highlights and Financial Results - GlobeNewsWire